AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 287: E269-E274, 2004. First published March 30, 2004; doi:10.1152/ajpendo.00040.2004
0193-1849/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/2/E269    most recent
00040.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Camacho, R. C.
Right arrow Articles by Wasserman, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Camacho, R. C.
Right arrow Articles by Wasserman, D. H.

Hepatic glucose autoregulation: responses to small, non-insulin-induced changes in arterial glucose

Raul C. Camacho, D. Brooks Lacy, Freyja D. James, Robert H. Coker, and David H. Wasserman

Department of Molecular Physiology and Biophysics, and Diabetes Research and Training Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232

Submitted 28 January 2004 ; accepted in final form 25 March 2004

The purpose of this study was to determine whether the sedentary dog is able to autoregulate glucose production (Ra) in response to non-insulin-induced changes (<20 mg/dl) in arterial glucose. Dogs had catheters implanted >16 days before study. Protocols consisted of basal (–30 to 0 min) and bilateral renal arterial phloridzin infusion (0–180 min) periods. Somatostatin was infused, and glucagon and insulin were replaced to basal levels. In one protocol (Phl ± Glc), glucose was allowed to fall from t = 0–90 min. This was followed by a period when glucose was infused to restore euglycemia (90–150 min) and a period when glucose was allowed to fall again (150–180 min). In a second protocol (EC), glucose was infused to compensate for the renal glucose loss due to phloridzin and maintain euglycemia from t = 0–180 min. Arterial insulin, glucagon, cortisol, and catecholamines remained at basal in both protocols. In Phl ± Glc, glucose fell by ~20 mg/dl by t = 90 min with phloridzin infusion. Ra did not change from basal in Phl ± Glc despite the fall in glucose for the first 90 min. Ra was significantly suppressed with restoration of euglycemia from t = 90–150 min (P < 0.05) and returned to basal when glucose was allowed to fall from t = 150–180 min. Ra did not change from basal in EC. In conclusion, the liver autoregulates Ra in response to small changes in glucose independently of changes in pancreatic hormones at rest. However, the liver of the resting dog is more sensitive to a small increment, rather than decrement, in arterial glucose.

glucose turnover; phloridzin



Address for reprint requests and other correspondence: R. Camacho, Dept. of Molecular Physiology and Biophysics, Vanderbilt Univ. School of Medicine, Nashville, TN 37232-0615 (E-mail: Raul.Camacho{at}vanderbilt.edu).







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.